Regencell Bioscience Holdings (RGC) Non-Current Assets (2020 - 2025)

Regencell Bioscience Holdings' Non-Current Assets history runs 6 years deep, the most recent figure standing at $656170.0 for Q4 2025.

• Quarterly Non-Current Assets changed N/A year-over-year to $656170.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $656170.0 (changed N/A YoY) and the FY2025 annual result came in at $852769.0, up 163.04% from the prior year.
• Non-Current Assets was $656170.0 for Q4 2025 at Regencell Bioscience Holdings, down from $852769.0 in the prior quarter.
• Across five years, Non-Current Assets topped out at $1.6 million in Q2 2022 and bottomed at $273285.0 in Q2 2021.
• A 5-year average of $780192.7 and a median of $754469.5 in 2025 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2022 — Non-Current Assets soared 476.07% — and 2024, when it sank 67.59%.
• Regencell Bioscience Holdings' Non-Current Assets stood at $273285.0 in 2021, then surged by 476.07% to $1.6 million in 2022, then plunged by 36.45% to $1.0 million in 2023, then sank by 67.59% to $324198.0 in 2024, then surged by 102.4% to $656170.0 in 2025.
• Business Quant data shows RGC's Non-Current Assets at $656170.0 in Q4 2025, $852769.0 in Q2 2025, and $324198.0 in Q2 2024.